Work

Abstract A87: Preliminary results of a phase II study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer.

Year: 2011

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-11-a87

Authors: Aaron T. Wild, Ariel E. Marciscano, Manuel Hidalgo, Daniel A. Laheru, Dung Le, Amy Hacker-Prietz, Mark A. Ziegler, Barish H. Edil, Phuoc T. Tran, Lei Zheng, Timothy M. Pawlik, Richard D. Schulick, Christopher L. Wolfgang, Joseph M. Herman

Institutions: Johns Hopkins University, Johns Hopkins Medicine, New York University

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2089789900

Cites:

Cited by:

Related to: 10